பலா மீஹான் நெஃப்ரான் ஆராய்ச்சி ஆய்வாளர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பலா மீஹான் நெஃப்ரான் ஆராய்ச்சி ஆய்வாளர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பலா மீஹான் நெஃப்ரான் ஆராய்ச்சி ஆய்வாளர் Today - Breaking & Trending Today

Mettler-Toledo International Inc (MTD) Q2 2021 Earnings Call Transcript


Operator
Good day, and thank you for standing by. Welcome to the Mettler-Toledo Quarterly Earnings Conference Call. [Operator Instructions]
I would now like to hand the conference over to your speaker today, Ms. Mary Finnegan. Please go ahead.
Mary T. Finnegan
Head of Internal Relations and Treasurer
Thank you, and good evening, everyone. I m Mary Finnegan. I m responsible for Investor Relations at Mettler-Toledo and happy to welcome you to the call. I m joined on the call today with Patrick Kaltenbach, our CEO; and Shawn Vadala, our Chief Financial Officer. Let me cover just a couple of administrative matters. This call is being webcast and is available for replay on our website. A copy of the press release and the presentation that we will refer to on today s call is also available on the website. ....

Dan Arias Stifel , Jack Meehan , Mary Finnegan , Dan Arias , Shawn Vadala , Maryt Finnegan , Patrick Kaltenbach , Vijay Kumar , Mettler Toledo International Inc , Jack Meehan Nephron Research Analyst , Us Securities Exchange , Nephron Research , Mettler Toledo Quarterly Earnings Conference , Internal Relations , Investor Relations , Chief Financial , Exchange Act , Management Discussion , Financial Condition , Chief Executive , Food Retail , Process Analytics , Eastern Drive , டான் அரியாஸ் ஸ்டிபேல் , பலா மீஹான் , மேரி ஃபிநிகெந் ,

Bio-Rad Laboratories, inc (BIO) Q2 2021 Earnings Call Transcript


Operator
Good afternoon, ladies and gentlemen, and welcome to the Q2 2021 Bio-Rad Laboratories, Inc. Financial Results Conference Call. [Operator Instructions]
I would now like to turn the conference over to your host, Mr. Edward Chung, Head of Investor Relations. Sir, please go ahead.
Edward Chung
Vice President of Investor Relations
Thank you, Joanna. Good afternoon. Thank you all for joining us. Today, we will review the second quarter 2021 financial results and provide an update on key business trends for Bio-Rad. With me on the phone today are Norman Schwartz, our Chief Executive Officer; Ilan Daskal, Executive Vice President and Chief Financial Officer; Andy Last, Executive Vice President and Chief Operating Officer; Annette Tumolo, President of the Life Science Group; and Dara Wright, President of the Clinical Diagnostics Group. Before we begin our review, I d like to caution everyone that we will be making forward-looking statements about management ....

Edward Chung , Jack Meehan , Patrick Donnelly , Patrick Donnelly Citi , Norman Schwartz , Adara Wright , Brandon Couillard Jefferies , Brandon Couillard , Annette Tumolo , Ilan Daskal , Dan Leonard , Bio Rad Laboratories Inc , Jack Meehan Nephron Research Analyst , Life Sciences , Clinical Diagnostics Group , Life Science Group , Wells Fargo , Nephron Research , Bio Rad Laboratories , Rad Laboratories , Financial Results Conference , Chief Executive Officer , Executive Vice President , Chief Financial Officer , Sandy Last , Chief Operating Officer ,